trials

Ultrapotent, nanoparticle COVID-19 vaccine with Univ. of Wash. roots gets $173M for human trials

by
Ultrapotent, nanoparticle COVID-19 vaccine with Univ. of Wash. roots gets $173M for human trials

An image of the nanoparticle with spike proteins used in a newly developed COVID-19 vaccine candidate. (Ian Haydon / UW Institute for Protein Design) A project to test what is known as an ultrapotent second-generation COVID-19 vaccine candidate will receive up to $ 173.4 million to conduct Phase 3 clinical trials. The vaccine was developed … Read more

Study finds major disparities in vaccine clinical trials over the past decade

by
Study finds major disparities in vaccine clinical trials over the past decade

Anthony Jackson, Safety Coordinator for the Fred Hutchinson Cancer Research Center, received a dose of the Pfizer-BioNTech COVID-19 vaccine on January 19 at a new vaccination clinic on the Fred Hutch campus. (Courtesy photo by Fred Hutch / Robert Hood) With data showing racial disparities in the distribution of COVID-19 vaccines, a new study found … Read more